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Recent studies showed wide variation in the extent to which
guidelines and other types of best practice have been
implemented as part of routine health care. This is also
true for the delivery of renal replacement therapy (RRT)
for ESRD patients. Increasing uptake of best practice within
such complex care systems requires an understanding of
implementation strategies and specific quality improvement
(QI) techniques. Therefore, we systematically reviewed
over 5000 titles published since 1990 and included papers
describing planned attempts to accelerate uptake of best
RRT practice into daily care. This resulted in a list of 93 QI
initiatives, categorized in order to expedite shared learning.
The majority of the initiatives were executed within the
domains of vascular access, nutrition, and anemia
management. Strategies oriented at patients were most
common and many initiatives pre-defined an improvement
target before starting implementation. Of the 93 initiatives,
22 were sufficiently robust methodologically to be analyzed
in more detail. Our results tend to support previous
findings that multifaceted strategies are more effective than
single strategies. Improving our understanding of how to
successfully implement best practice can inform system-level
change and is the only way to close the gap between
knowledge on what works and the actual care delivered to
ESRD patients. Research into implementation, using specific
QI techniques, should therefore be given priority in future.
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published online 20 July 2011
KEYWORDS: chronic kidney failure; kidney transplantation; quality improve-
ment; renal dialysis; review
In order to improve outcomes for patients with end-stage
renal disease (ESRD), a continuous effort is being made to
define best practice in the field of renal replacement therapy
(RRT). PubMed currently lists over 150,000 citations of
studies on RRT for ESRD patients. This indicates that there is
a large body of knowledge on best practice. Although this is
encouraging, it is also impossible for clinicians to assimilate
all the evidence. This has driven the development of position
statements and of knowledge syntheses in the form of clinical
practice guidelines,1–7 which are remarkably consistent in
their recommendations for best RRT practice. However,
a large gap remains between what is considered to be
best practice and the actual delivery of routine health
care, implying that not all patients receive optimal care
according to available knowledge.8–11 This is also true for
ESRD patients receiving RRT;12,13 part of the variation in
outcomes between dialysis facilities can be explained by
differences in the degree to which care delivery matches best
practice.14–16
The delivery of RRT is complex: patients have life-long
disease, frequent co-morbidity, involvement of multiple
health professionals, and multiple health-care settings. In
such complex settings, achieving change is difficult.17–19 It
cannot simply be accomplished by having knowledge on
best practice available9,10,20 or by clinical teams ‘trying
harder’; instead, it requires a clear understanding of how to
use proven strategies and specific quality improvement (QI)
techniques to guide implementation of best practice. The
gap between best practice and current practice may partly
exist because such strategies and techniques are not familiar
to many clinicians. Furthermore—until recently—papers on
how to implement best practice received scant attention in
high-impact medical journals. Nevertheless, many systematic
attempts to improve the delivery of care to RRT patients have
been described, and a number of them are likely to provide
valuable information for clinicians seeking to improve the
quality of care in their own systems.
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Therefore, we systematically reviewed the literature
published since 1990 to identify quantitative evaluations of
QI initiatives in the field of RRT. We defined a QI initiative
as using an implementation strategy (that is, a planned and
systematic attempt) to introduce or improve the uptake
of elements of care that could be considered to be established
best practice. We aimed to answer the following research
questions: (1) Which strategies and specific QI techniques have
been used in QI initiatives in RRT to implement best practice?
(2) What was the effect of these QI initiatives on the quality of
RRT care?
RESULTS
We found 2397 original papers and 55 reviews by searching
MEDLINE (PubMed), CINAHL, and the Cochrane library
for original peer-reviewed articles and reviews in English
published in the period January 1990 to February 2010. Initial
screening of titles and abstracts of the original papers resulted
in 131 articles for full text screening, of which 74 were
included. The reference lists of these included papers and
of the 55 reviews from the main search contained 2644 titles,
of which 36 were selected for full text screening and
22 for final inclusion, adding up to 96 included papers.
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* Reasons for exclusion of full papers (n = 71)
• Effect of quality improvement initiative not quantitatively evaluated (n = 27)
• Lack of planned implementation strategy (n = 21)
• Lack of baseline measurement (n = 12)
• Lack of description of best practice (n = 4)
• Outcome measurement not directly related to RRT patients (n = 4)
• No original article, for example editorials (n = 3)  
Figure 1 | Search strategy and search results. aA total of 129 reference lists from 74 included original articles and 55 reviews. bOf the
96 included papers, 26 papers concerned evaluations with an external control group. CARI, Caring for Australasians with Renal Impairment;
EBPG, European Best Practice Guidelines; KDOQI, Kidney Disease Outcomes Quality Initiative; RRT, renal replacement therapy.
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Of those, 26 concerned studies that evaluated the difference in
improvement between an intervention group and an external
control group. Common reasons for exclusion of full papers
were lack of a quantitative evaluation of the initiative’s effect
or lack of a planned implementation strategy (Figure 1).
Implementation strategies
The 96 papers described 93 different QI initiatives, all
of which used at least one of the strategies listed in
Table 1 to implement best practice; the strategies that were
used within each initiative are described in Table 2. The
numbers in the table are references numbers (except for those
in the last row). We categorized the initiatives based on RRT
domain. Initiatives consisting of a single element (n¼ 26)
mostly concerned a patient-oriented strategy (n¼ 15) or a
treatment protocol (n¼ 6). Also, within multifaceted inter-
ventions (n¼ 67), a strategy oriented at patients was the most
common element (n¼ 40), followed by an educational
strategy aimed at clinicians (n¼ 38), an organizational
staff-oriented intervention (n¼ 38), or a treatment protocol
(n¼ 29). One multifaceted initiative used a financial strategy
as one of the elements21 (not displayed in Table 2). Initiatives
using multiple implementation strategies appear in multiple
columns. The implementation strategies used in each QI
initiative are described in more detail in Supplementary
Appendix A online.
The majority of the QI initiatives were executed within the
domains of vascular access (n¼ 22), nutritional management
(n¼ 20), and anemia management (n¼ 15). These three
domains are discussed in more detail below. The other nine
domains contained a maximum of seven QI initiatives.
In vascular access, more than half of the initiatives used a
combination of four or more strategies (n¼ 12), for example,
a care pathway coordinated by a vascular access nurse,
educating patients on the importance of timely permanent
access and shifting access surgery from inpatient to out-
patient facilities.22 The Save the Vein Program23 consisted
of a combination of procedures to ensure timely selection
and referral of patients for permanent access surgery, the
recruitment of a vascular surgeon with special expertise in
fistula creation, and educational activities aimed at hospital
nursing staff to protect veins in the designated arm from
venipuncture.
Within the domain of nutritional management, patient-
oriented strategies were used in 18 initiatives. Examples are
educational group sessions focusing on fluid intake,24–27
individual patient counseling to increase adherence to
phosphate binders,28–30 or the completion of a food diary
by the patient to record and control phosphate intake31–33
or potassium intake.34 A total of 13 initiatives had patient-
oriented strategies as their only element. Other types of
strategies were relatively rare in this domain.
Table 1 | Strategies to implement best practice in daily care and examples within RRT care (based on work of the Cochrane
EPOC Group101–103)
Implementation
strategy Description of the strategy Examples within RRT care
Health professional-oriented strategies
Educational activities Aimed at increasing provider’s knowledge on (best)
clinical practice
Dissemination of guidelines, workshops on how to
increase dialysis adequacy
Audit and feedback Any information or summary of clinical performance
over a specified period of time; the information can
be obtained by the caregivers themselves or provided
by others
Feedback reports comparing quarterly center-specific
fistula rates with national averages, local multidisciplinary
meeting discussing episodes of peritonitis that occurred
the past month
Treatment protocols/
algorithms
Aimed at supporting providers with performing a desired
clinical action at the time of the patient encounter;
protocols and algorithms can be computerized or
provided on paper
Algorithm recommending EPO dose based on patient’s
Hb level, instructions on how to perform cannulation in
vascular access care
Reminders Aimed at prompting providers to arrange follow-up care
resulting from a patient encounter; reminder systems can
be manual or computerized
Follow-up appointment system (e.g., stickers on charts),
protocolized care pathway to streamline referral to
vascular surgeon
Organizational strategies
Structural Changes in the physical structure of health-care facilities
or in information management
Moving access surgery from inpatient to outpatient
facilities, building an additional dialysis unit, system to
track patients’ vaccination status
Staff-oriented Changes in roles, responsibilities, numbers, or types
of staff
Nurse taking over anemia management from
nephrologist, shift from individual physician care to
multidisciplinary team-based care, vascular access
coordinator as case manager
Financial strategies Economic measures or sanctions aimed at providers
or institutions
Payment for performance, financial penalties for
inappropriate action
Patient-oriented
strategies
Aimed at improving practice by directly involving the
patient
Nutritional counseling, patient education to facilitate
involvement in modality choice, patient reminders to
take phosphate binders
Abbreviations: EPO, erythropoietin; EPOC Group; Effective Practice and Organisation of Care Group; Hb, hemoglobin; RRT, renal replacement therapy.
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All initiatives on anemia management had a treatment protocol
as part of their strategy (n¼ 15), mostly on intravenous iron
administration and erythropoiesis-stimulating agent dosing; some
also focused on the causes of erythropoiesis-stimulating agent
resistance.35–38 Two anemia programs used a computerized dosing
algorithm.39,40 Anemia protocols were frequently combined with a
staff-oriented strategy (n¼ 8), such as the appointment of a
designated anemia manager35,37,38,41 or pharmacist responsible for
anemia management of all patients.42,43
Specific QI techniques used to guide the implementation
of best practice
Of all 93 QI initiatives, 66 described the use of at least
one specific QI technique to prepare, monitor, or deliver
the implementation of best practice. Table 3 presents the
(combinations of) techniques used within the QI initiatives;
the following text contains illustrative examples of specific QI
techniques used in RRT practice.
Regarding the preparation of the implementation, more
than half of all QI initiatives (n¼ 49) quantified the oppor-
tunity for improvement before starting the implementation
process, for example, by using data from the Clinical
Performance Measurement project from the Centers for
Medicare and Medicaid Services.44 Using the analysis of
possible barriers to changing current practice as input for the
development of the implementation strategy was mentioned
frequently (n¼ 37), for example, by organizing brainstorm
sessions with caregivers and/or patients, by using specific
tools (such as Fishbone diagrams), or by reviewing the
literature. The predefinition of an improvement target—for
example, as defined in a guideline or by using the results of
high-performing centers as a standard—was less common
(n¼ 20). Only 12 initiatives reported having used all three
preparatory techniques.
Data-driven monitoring of the effect of the initiative
during the implementation process was done by 39
initiatives. Regarding delivery of the implementation, 27
initiatives reported the appointment of a dedicated QI team
or coordinator to manage the local QI process. Also, 17
initiatives explicitly described the use of QI expertise in the
initiative, for example, by instructing QI team members on
how to use QI techniques45–52 or supervision of the
implementation process by an advisory board.21,47,48,51,53–57
Within the domain of vascular access, the use of specific
QI techniques was most common: 19 of the 22 initiatives
used at least one QI technique and 11 of them used a
combination of 43 techniques. For example, in one QI
initiative, a multidisciplinary task force analyzed baseline
data of all participating dialysis centers, summarized targets
for improvement, and organized regular meetings. Local QI
teams were identified with a vascular access nurse as a key
member. National coordinators visited dialysis centers to
support local implementation and several performance
variables were prospectively monitored and discussed.58
Effectiveness of QI initiatives
We rated all controlled studies for risk of bias according
to five potential sources of bias,59 with a maximum overall
Table 2 | Implementation strategies used in QI initiatives in RRT care (the numbers in the table are reference numbers; except
for those in the last row)
Health professional-oriented strategies Organizational strategies
Domains of RRT
care (number
of initiatives) Education
Audit and
feedback
Treatment
protocols Reminders Structural Staff-oriented
Patient-oriented
strategies
Anemia management
(n=15)
35, 41, 42,
108, 109
— 35–38, 40a, 41–43,
91, 108, 109, 110b,
111–114
— — 35–38, 42, 43, 45,
109, 113
91, 108, 114
Cardiovascular risk
management (n=2)
115 — 116 — — 116 115, 116
Care coordination
across domains (n=3)
21 117 — — — 21, 117, 118 21, 118
Dialysis dose (n=6) 47–49, 51, 119 47–49, 51, 119, 120 49 120 — — 119, 120
Nutritional
management (n=20)
46, 121, 122 46, 123, 124 28, 30,121,
125
121–123 28 28, 30, 34, 46 24–30, 31b, 32–34, 46,
121–123, 126–128
Peritoneal dialysis
(n=5)
129 130 129 — 52 52, 129, 131 129–132
Preparation for
RRT (n=7)
133 133 — 50a 134c 134, 135b, 136 50a, 134c, 135b,
136, 137
Rehabilitation (n=2) 53 — — — 53 — 138
Transplantation (n=3) — — 139 139 139, 140b 140b 139, 141
Vaccination (n=3) 142–144 143 142 144 142, 144 142 143, 144
Vascular access
(n=22)
23, 56–58,
145–157
56, 57, 147–150,
153,154, 157–159
56–58, 145–147,
155, 160, 161
22, 23, 56–58,
145–152, 159
22, 147–149, 157,
158, 161–163
22, 23, 56, 57,
146, 148, 149, 151,
153–160
22, 23, 56–58, 145, 146,
148, 149, 151, 153, 154,
157, 161
Multidomain (n=5) 164, 165 54, 55, 164, 165 45, 165 — 165 — 165
Total number
of initiatives
38 26 35 20 18 38 55
Abbreviations: QI, quality improvement; RRT, renal replacement therapy.
aComputerized.
bQI program focusing on children (o21 years old).
cPaper describes two separate QI initiatives that both use this type of implementation strategy.
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‘protection’ score of 10 (see Supplementary Appendix B
online). Of the 26 controlled studies, 22 were considered to
be adequately protected against bias, that is, having an overall
score of at least 7, and were included for analyzing the
effectiveness of QI initiatives (Table 4); 12 (55%) of these 22
evaluations reported an improvement of the quality of RRT
care, 10 (45%) found no effect, and none of them found a
negative result.
Eleven of the adequately protected studies evaluated a QI
initiative that consisted of more than one implementation
strategy; 8 (72%) of these multifaceted initiatives reported a
positive effect vs three (28%) studies reporting no effect on the
primary outcome measures. Of the 11 initiatives using a single
strategy, 4 (36%) found a positive effect and 7 (64%) reported
no effect. The higher effectiveness of initiatives using multiple
implementation strategies compared with those using a single
strategy was borderline significant (P¼ 0.087).
A total of 10 studies evaluated an initiative that used at
least one specific QI technique: 7 (70%) reported a positive
effect vs 3 (30%) studies reporting no effect. Of the 12
initiatives not using QI techniques, 5 (42%) had a positive
and 7 (58%) had no effect. There was no association between
the use of at least one specific QI technique and the
effectiveness of the initiative (P¼ 0.184).
DISCUSSION
Principal findings
In our review, we identified 93 QI initiatives that aimed to
implement knowledge on best practice into daily RRT care.
Most initiatives used multiple implementation strategies and
many described the use of specific QI techniques to guide
the implementation process. Our results tend to support
previous findings that combining multiple strategies is more
effective than using a single strategy. However, we did not
find an association between the use of specific QI techniques
and the effectiveness of an initiative.
Identification of relevant QI initiatives
It is possible that we missed some relevant studies. There is a
lack of a generalizable taxonomy for QI publications,60,61
which hinders the identification of QI initiatives in literature
using an electronic search consisting of MeSH terms and key
words. Therefore, we complemented our main search with a
hand search of reference lists. Publication bias is a second
possible reason for missing relevant QI initiatives; the
scientific merit of reporting on QI initiatives has only been
accepted relatively recently.62 Also, the lack of incentive to
invest resources63 and the lack of clarity regarding regulatory
requirements for QI studies, for example, ethical review,64,65
might hamper the evaluation and publication of small-
scale QI initiatives. Searching trial registries such as www.
clinicaltrials.gov—to further investigate the extent of the
publication bias—is hampered by the limited search options
in such registries and the complexity of a search strategy as
used in our review. Moreover, some larger-scale QI initiatives
in RRT care were excluded from our review, because they
lacked a quantitative evaluation of the initiative’s effective-
ness,66,67 possibly because of methodological challenges.68
Publication and citation bias might also explain why we
did not find studies reporting a negative effect;69 although
we did not expect QI initiatives to worsen outcomes of care,
we cannot exclude unintended consequences.
Regarding the studies that we did identify, we chose to
include any quantitative evaluation of a QI initiative that
Table 3 | Specific QI techniques used to guide implementation of best practice in RRT care (the numbers in the table are
reference numbers; except for those in the last row)
Preparation of the implementation Delivery of the implementation
Domains of RRT
care (number
of initiativesa)
Barrier analysis
as input for strategy
development
Predefined
opportunity for
improvement
Predefined
improvement
target
Data-driven
monitoring of
the effect
Dedicated
resources
CQI
expertise
Anemia management
(n=10)
35, 41, 108, 114 35, 37,38, 41, 42,
109–111, 113, 114
108 37,38, 108, 114 35, 37,38, 41,
109, 114
—
Cardiovascular risk
management (n=1)
— — 115 — — —
Care coordination
across domains (n=2)
— — — 21, 117 21, 117 21
Dialysis dose (n=6) 51, 119, 120 47–49, 119 47, 48, 119 47–49, 51, 119 47 47–49, 51
Nutritional
management (n=9)
46, 121–124 24, 34, 46, 121 121 46, 121, 124, 125, 127 46, 121 46
Peritoneal dialysis (n=4) 52, 129, 130, 132 52, 129, 132 129 129, 130 52, 130 52
Preparation for
RRT (n=2)
50 50, 133 — 50 50 50
Rehabilitation (n=2) 53, 138 53 53 53 — 53
Transplantation (n=3) 139, 140a, 141 139, 140b — 139 139 —
Vaccination (n=3) 144 142–144 144 143, 144 — —
Vascular access
(n=19)
23, 56, 58, 146–150,
152–154, 157, 159, 161
23, 56–58, 146,
150; 152–161, 163
23, 56–58, 148, 149,
152–154, 157, 158, 161
23, 57, 58, 146–151,
153–155, 157, 159, 161
23, 57, 58, 146–149,
152–155, 157, 161
23, 56–58,
150
Multidomain (n=5) 45, 164 45, 54, 164, 165 164 45, 55, 164, 165 45, 165 45, 54, 55
Total number of
initiatives
37 49 20 39 27 17
Abbreviations: QI, quality improvement; RRT, renal replacement therapy.
aNumber of QI initiatives using at least one specific QI technique.
bQI program focusing on children (o21 years old).
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implemented any type of best practice in any RRT domain
on any scale. This resulted in an extensive list of initia-
tives variable in scope, content, and design. On one hand, the
heterogeneity of implementation strategies and reported
outcome measures hampered the summarizing of effect
sizes in, for example, a forest plot,70 and thus from drawing a
firm conclusion on which strategies are most effective;
to improve this, harmonizing the content and design of
new QI evaluations with studies previously reported in
literature should guide future research. On the other hand, as
it is useful to have an overview of QI initiatives already
undertaken by others,62,71,72 readers can select initiatives
from our list that fit their local context and learn from them.
Relation to other studies
Previous systematic reviews regarding the implementation of
best practice have been published. Some of them concerned
implementing any kind of best practice in any medical
domain, either including a broad range of interventions73 or
focusing on one specific strategy, such as audit and feed-
back.74,75 Our finding that combining multiple strategies
tends to be more effective than using a single strategy is in
line with the conclusion of these reviews. Others evaluated
the effectiveness of any QI strategy to implement one specific
type of best practice, such as the management of hyperten-
sion.76 Similar to our study, the majority of the QI initiatives
included in this review concerned multifaceted interventions,
but no comparison was made between single and multiple
strategies. The authors did state, however, that by inspection
they did not find a clear pattern of increasing or decreasing
effect as the number of strategies increased. Unfortunately,
we can neither confirm nor deny this conclusion based
on our results. Weingarten et al.77 investigated the effect of
a range of QI interventions on the management of several
chronic conditions. More than half of the included QI
initiatives consisted of a combination of strategies, but they
did not compare them with single-element interventions.
In line with our review, patient-oriented strategies were most
common.
Overall, studies concerning RRT care were rare or absent
in any of the abovementioned reviews. Hence, to our
knowledge, we are the first to present a broad overview of
strategies to implement best practice in this specific medical
domain and to report on their effectiveness in improving
outcomes for ESRD patients.
Common strategies to implement best practice in RRT care
In our review, the most frequently used implementation
strategies were patient oriented. A possible explanation is that
care providers consider these strategies easier to imple-
ment, because often no additional investment or structural
change is required. The high number of patient-oriented
strategies might also reflect the fact that patient compliance
and empowerment are central themes in chronic care.18,78
Patient-oriented strategies were especially common in the
domain of nutritional management, often without being
combined with other strategies. On one hand, this is not
surprising, as ensuring concordance between patients and
caregivers is an essential part of increasing patient adherence to
the recommended dietary restrictions and use of binders. On
the other hand, we had expected to find more variety in the
design of these patient-oriented strategies: the large majority
concerned face-to-face educational sessions taking place at
the dialysis facility, whereas in other medical domains, such
as glycemic control in diabetes type 2 patients, for example,
web-based interventions have been successful in implementing
best practice.79 Also, a recent meta-analysis across medical
domains found a modest effect of web-based interventions
on patient empowerment and self-efficacy.80 Hence, although
there may be obvious differences between the management of
ESRD and other diseases, it might be worthwhile to explore
implementation strategies used in other medical domains that
encounter similar disease management problems.
Furthermore, the multidisciplinary character of RRT care
might explain the frequent use of staff-oriented strategies. For
example, in the domain of vascular access care, communica-
tion with other disciplines—such as vascular surgeons—is a
critical aspect of the access care pathway. This is reflected in
the type of strategies used, such as case management by a
vascular access nurse or shifting from individualized physician
care to team-based care. From this, we might conclude that
the type and complexity of the care pathway determines to a
great extent the type and complexity of strategies used to
implement best practice.
Use of QI techniques to guide implementation of best
practice in RRT care
The use of specific QI techniques was most common in the
domain of vascular access. This might be explained by the
fact that the NKF-KDOQI (National Kidney Foundation
Kidney Disease Outcomes Quality Initiative) guidelines
on vascular access promoted the use of these techniques for
improving the delivery of vascular access care, for example,
by incorporating a target rate for arteriovenous fistula
placement to be achieved by dialysis facilities.81 Additionally,
the Fistula First Breakthrough Initiative57,82—a nationwide
project to improve vascular access care in the United States—
facilitates data-driven preparation and monitoring of local
implementation of the guideline by collecting and reporting
benchmarked data on access care. Another initiative that
aims to enable data-driven comparison of actual care delivery
with clinical practice guidelines is the NephroQUEST
(Nephrology QUality European Studies) project. Within this
project, a standardized set of quality of RRT care indicators
was developed based on European Best Practice Guidelines,
and national registries throughout Europe were motivated
and supported to collect data on these indicators.83,84
Effectiveness of QI initiatives
Although some have argued that it is not always required
to include an external control group when studying the
effectiveness of QI initiatives,85 many others advocated the
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need for rigorous evaluations.63,86,87 This is even more
important because the impact of QI interventions is not
always as high as expected.88–90 Thus, to draw conclusions on
the effectiveness of QI initiatives in RRT, we only regarded a
minority of studies that we assessed as being sufficiently
robust methodologically, that is, including an external
control group and being adequately protected against bias.
On one hand, this limited our ability to investigate the
relationship between the use of implementation strategies
and specific QI techniques and the effectiveness of initiatives;
on the other, it increased the methodological robustness of
our review. To further strengthen this robustness, we marked
evaluations as finding ‘no improvement’ when they lacked a
test for statistical significance, even when they reported a
clear positive trend.33,91
As mentioned before, we can conclude from our review
that the conclusion from previous research that the use of
multiple implementation strategies is more effective than
using a single strategy73,74,92 also seems to apply to QI in RRT
care. However, we did not find that using at least one specific
QI technique to guide implementation of best practice was
more effective than using no QI techniques at all. This might
imply that also for these techniques to be effective, multiple
techniques must be combined instead of using a single one.
Schouten et al.93 evaluated the impact of QI collaboratives
that incorporated most of the techniques as specified in our
study, and found a positive but limited effect on the quality
of care. Unfortunately, the lack of rigorously evaluated QI
initiatives in RRTand the resulting lack of power of our study
did not allow us to analyze the relationship between the
number of specific QI techniques and the effectiveness of
initiatives. As long as the belief in and use of QI techniques
is spreading, and substantial investments of valuable
resources are made, the need for high-level evidence persists.
Therefore, future systematic reviews addressing this issue
should aim to identify a larger set of studies evaluating
initiatives that used a combination of QI techniques to guide
implementation of best practice, for example, by broadening
the scope from RRT care to the management of any chronic
condition.
The gap between best practice and routine delivery of
RRT care
In our introduction, we mentioned the gap between what is
considered to be best practice and the actual delivery of
routine RRT care. Besides differences in implementation
strategies, another explanation for this gap might be the
degree of clinicians’ agreement with best practice.94 A lack of
agreement may result from lack of strong evidence base95,96
or trials reporting negative effects of adhering to best
practice, reducing physicians’ adherence to guidelines.
Nevertheless, availability of high-level evidence in itself is
no guarantee for optimal adoption of knowledge on best
practice: despite robust evidence of the association between
suboptimal doses of hemodialysis and poor outcomes—
available since the 1981 randomized National Cooperative
Dialysis Study97—there are persisting differences between
countries in the percentage of patients achieving a target Kt/V
of at least 1.2.98 Still, some might hypothesize that part of the
practice variation is caused by variation in the extent to
which physicians and other caregivers agree with the avail-
able guidelines. Although some have investigated barriers
to guideline adherence in RRT care,99 we are not aware of
any studies that have specifically examined the relationship
between caregivers’ endorsement of, or trust in, clinical
practice guidelines in RRT and adherence to those guidelines.
This should be addressed in future research. Additionally,
Tinetti et al.100 pointed out that adhering to every applicable
disease-specific guideline might even cause harm to patients
with chronic disease and multiple conditions; for example, as
a result of unforeseen interactions between treatments
recommended by different guidelines, or because of the
unknown long-term consequences of certain medications.
Also, they stated that especially elderly patients and those
with multiple conditions do not necessarily value the
potential benefits from adhering to the guideline (for
example, longer survival or prevention of adverse events) as
much as other patients. Part of the nonadherence to best
RRT practice might therefore be because of patient prefe-
rences and limited applicability of guidelines to ESRD
patients due to frequent co-morbidity.
In conclusion
We systematically reviewed over 5000 titles published since
1990 and included papers describing planned, systematic
attempts to promote the uptake of best practice into routine
delivery of RRT care. This resulted in a list of 93 QI initiatives
that varied in scope, content, and design. Readers may use
this list to select initiatives that fit their local context and
learn from them. Our ability to draw firm conclusions on the
relationship between the implementation strategies and
specific QI techniques used and the outcomes achieved was
limited, as only a small number of studies that we assessed
were of sufficient methodological quality. However, as shown
by the large number of papers that we reviewed, there is a lot
of interest in the subject of how to improve the delivery of
evidence-based care to patients on RRT. This is encouraging,
because improving our understanding of how to successfully
implement best practice is the only way to close the gap
between knowledge on what works and the care actually
delivered to ESRD patients. Also, the results from high-
quality evaluations—as included in our review—can inform
system-level changes required to achieve improvement.
Research into implementation, using QI techniques, should
therefore be given priority in future.
MATERIALS AND METHODS
Search strategy
We searched MEDLINE (PubMed), CINAHL, and the Cochrane
library for original peer-reviewed articles and reviews in English
published in the period January 1990 to February 2010. The
search strategy consisted of MeSH terms related to QI and terms in
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title/abstract referring to QI or specific guideline initiatives,
combined with MeSH terms regarding RRT for ESRD patients
(Figure 1). The complete list of terms and the syntax of the
MEDLINE search can be found in Supplementary Appendix C
online. Additionally, we hand searched the reference lists of all
relevant reviews and of original articles included following the main
search.
Inclusion of relevant papers
We aimed to identify studies that evaluated the effectiveness of
QI initiatives implementing knowledge on best RRT practice using
an implementation strategy. For this review, knowledge on best
practice referred to an evidence-based (set of) clinical action(s)—
usually described in a local, national, or international clinical
practice guideline—that is considered to be applicable to all patients
or a subgroup of patients, independent of the health-care facility
where they are treated. We excluded studies that attempted to
identify the clinical actions that would result in improved clinical
outcomes. We defined an implementation strategy as a planned
and systematic attempt to introduce or improve uptake of
knowledge on best practice into daily clinical care. It concerns
organizing the delivery of care in such a way that health-care
professionals are (better) enabled to apply knowledge on best
practice. For example, within an anemia management program, best
practice might be achieving a target hemoglobin value by
administering an erythropoiesis-stimulating agent. A possible
matching implementation strategy is a computerized algorithm
for the dosing recommendations of the erythropoiesis-stimulating
agent.
We included studies evaluating a QI initiative containing at least
a description of or a reference to a type of best practice and a
description of an implementation strategy. Furthermore, in order to
limit the spectrum of how the effectiveness of QI initiatives was
evaluated, studies had to report on clinical process or outcome of
care measures directly related to RRT for ESRD patients; thus
excluding studies solely reporting on, for example, outcomes for
patients with acute kidney failure or chronic kidney disease not
yet on dialysis, patients’ dietary knowledge level, or job satisfaction
of renal nurses. Last, we only included studies with a quanti-
tative evaluation consisting of at least a baseline and follow-up
measurement.
All titles and abstracts were judged for relevance according to the
above criteria. The full text of the articles was screened before
deciding on final inclusion. Each title/abstract and full text was
screened independently by the principal reviewer (SNV) and one
of the other reviewers (AMN, CRVT, DR, JH, or KJJ). In case of
disagreement we reached consensus through discussion.
Data collection
We developed, tested, and finalized a data abstraction form that was
structured in five sections (Supplementary Appendix D online). The
first section regarded general information on the QI initiative, such
as the domain of RRT care (for example, vascular access) and the
level at which the initiative was executed (for example, single
center). In the second section, we described the best practice that
was being implemented and the highest level of authority suppor-
ting the best practice, ranging from international guidelines based
on a formal synthesis of available evidence to local expert opinion.
The third section of the form contained a list of implementation
strategies based on the classification of the Cochrane Effective
Practice and Organisation of Care (EPOC) Group.101–103 Table 1
presents the strategies including a description and examples within
RRT care.
The fourth section concerned specific QI techniques that can be
used to guide the implementation of best practice.65,104–107 It
included items relevant to the preparation of the implementation
(for example, performance data used to quantify the opportunity for
improvement before initiating the QI initiative), the monitoring of
the quantitative effect of the initiative during the implementation
process, and items regarding the delivery of the implementation (for
example, appointment of a local QI team). The last part of the
abstraction form covered the reported effect of the QI initiative. This
part was applied only to controlled studies—that is, studies using
other facilities or patients as (external) controls—that provided
sufficient details to judge if there was a difference in change
improvement between groups. Five items involved assessing the risk
of bias on a 10-point scale, with a total score of ‘10’ meaning an
optimal protection against bias (see Supplementary Appendix B
online).59 Other items concerned the groups compared in the study
and the reported effect on the primary clinical outcome measures.
The principal reviewer abstracted the relevant data for all
included articles. The other reviewers independently did the same
for the articles allocated to them. For each article, the captured
information was compared and differences were discussed until
consensus was reached. When information for completing the data
abstraction form was missing, additional sources—such as websites
or cited literature—were consulted.
Data analyses
To describe the implementation strategies and specific QI techniques
used, we grouped the initiatives based on the domain of RRT care.
For the reporting of the effectiveness of initiatives, we only took into
account controlled studies that we considered to be adequately
protected against bias, that is, having an overall ‘protection’ score of
at least 7. We described each controlled study separately, including a
quantification of the effect size and whether the initiative led to a
statistically significant improvement. For studies that defined several
primary outcome measures, we only reported the effect on those
measures that we considered to best match the aim of the QI
initiative. For example, for a QI initiative aimed at improving
dialysis adequacy,47 we only reported the proportion of patients
achieving the urea reduction ratio target, and disregarded measures
like average time on dialysis and mortality rates. Evaluations that
did not test the statistical significance of the effects of the QI
initiative were reported as ‘no improvement’.
Based on previous research,73,74,92 we hypothesized that
initiatives using more than one strategy would have more effect
on the quality of RRT care than initiatives consisting of a single
strategy. We also expected that QI initiatives using at least one
specific QI technique to guide the implementation process would be
more successful than initiatives using no QI techniques. To test these
hypotheses, we used Pearson’s w2 test.
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